Table 1:
Demographic and clinical characteristics
EOS | HC | Statistics | ||
---|---|---|---|---|
| ||||
Age (years) | 19.83 (1.47) | 19.64 (1.64) | t=0.47, df 74, p=0.64 | |
| ||||
Sex | ||||
Male | 8 | 17 | χ2=5.51, df 1, p=0.02 | |
Female | 15 | 26 | ||
| ||||
Duration of illness (years) | 1.43 (2.70) | 0 | -- | |
| ||||
PANSS score * | Total | 59.52 (14.68) | 31.13 (2.51) | F(1,76)=147.07, p<0.001 |
Positive | 16.96 (4.52) | 7.17 (0.51) | F(1,76)=184.08, p<0.001 | |
Negative | 12.96 (4.44) | 7.57 (1.67) | F(1,76)=40.96, p<0.001 | |
General | 29.61 (7.50) | 16.40 (1.35) | F(1,76)=132.65, p<0.001 | |
| ||||
PCET Total score | 26.43 (8.89) | 35.08 (8.42) | F(1,76)=3.98, p=0.05# | |
| ||||
WASI Total | 100.78 (12.23) | 107.59 (11.23) | F(1,76)=1.27, p=0.26# |
MANCOVA model consisting of PANSS component scores covarying for age, sex, and medications, Wilk’s λ=0.263, F=64.50, p<0.001
Covarying for age, sex, and medications